B cells can act alone in autoimmune disease

Aug 07, 2008

B cells, the source of damaging autoantibodies, have long been thought to depend upon T cells for their activation and were not considered important in the initiation of autoimmune diseases like lupus or rheumatoid arthritis.

In the Aug. 7 online issue of the journal of Immunity, Yale University researchers turn this paradigm on its head by showing that in systemic autoimmune diseases B cells can be activated the absence of T cells.

The study suggests new ways to intervene in the immune system's chronic attacks on the body's own tissue.

The findings were surprising because many scientists believed that B cells remain quiet in autoimmune diseases unless they are stimulated first by T cells, said Mark Shlomchik, MD, professor of laboratory medicine and immunobiology at the Yale School of Medicine and senior author of the study.

"It became a chicken or egg problem. If cooperation between T and B cells is needed to create an autoimmune disease, who falls off the fence first, and why?'' Shlomchik said.

Recently this same Yale group along with collaborators at Boston University discovered an unexpected role in autoimmunity of Toll-like receptors, previously thought to be stimulated by molecules expressed on microbial pathogens. Shlomchik and his colleagues showed that they can also recognize and react to "self" molecules, in particular mammalian DNA and RNA. When this occurs, these receptors help activate B cells that make the classical autoantibodies of lupus.

The new Yale study now shows that these signals substitute for T cells in starting the autoimmune process in B cells. The researchers propose that once B cells are activated via Toll-like receptors, they can subsequently recruit T cells and that this can lead to a "vicious cycle" of chronic autoimmune disease in which the two types of cell activate each other.

The findings might explain why treatments that target T cells in autoimmune diseases have fared relatively poorly, while newer treatments aimed at B cells have shown great promise, he said.

The current study is a direct outgrowth of groundbreaking work conducted at Yale over the last 15 years that showed that elements of the innate, or non-specific immune system such as Toll-like receptors, needed to be triggered before more sophisticated adaptive immune system of humans and other animals could hone in on specific pathogens.

Source: Yale University

Explore further: Bird flu confirmed in Canadian patient after China trip

add to favorites email to friend print save as pdf

Related Stories

Journalist linked to Anonymous gets five years' prison

10 hours ago

A journalist also known as an informal spokesman for the hacker group Anonymous was sentenced to five years in prison Thursday in a case which rallied activists for press freedom, his supporters said.

Drought sees Rio's main hydro plant turned off

10 hours ago

A major Rio hydroelectric power plant was switched off after water levels slipped below an operational minimum following severe drought, Brazil's national grid told AFP on Thursday.

Recommended for you

Pre-op back pain, pain sensitivity predict outcomes

23 minutes ago

(HealthDay)—Preoperative back pain and individual pain sensitivity can predict postoperative pain following lumbar surgery, according to a study published in the December issue of Pain Medicine.

Senegal opens Guinea border as Ebola recedes

5 hours ago

Senegal reopened its land border with Guinea on Monday, pointing to the "significant efforts" of its neighbour in fighting an Ebola outbreak that has claimed thousands of lives.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.